NCT02416115View on ClinicalTrials.gov

Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled Analgesia

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG

Ramosetron

Ramosetron was given iv.

DRUG

Naloxone

Naloxone added to PCA was given iv.

DRUG

saline

Saline was given iv.

DRUG

Morphine

Morphine in the PCA was given iv.

All Listed Sponsors

lead

Kyungpook National University Hospital

OTHER

NCT02416115 - Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled Analgesia | Biotech Hunter | Biotech Hunter